Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
Chang
Chung-Che
CC
Cleveland
Ronald P
RP
D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000276:immunology / Q000378:metabolism; D001854:Bone Marrow Cells / Q000276:immunology / Q000473:pathology; D018450:Disease Progression; D006801:Humans; D015448:Leukemia, B-Cell / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism*; D008562:Membrane Glycoproteins; D022423:Myeloid Cells / Q000276:immunology / Q000473:pathology; D009244:NAD+ Nucleosidase / Q000378:metabolism*; D011379:Prognosis
D015703:Antigens, CD; D000943:Antigens, Differentiation; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1